annual meeting program - American Society of Clinical Oncology

MONDAY
Monday, June 7, 2010
9:30 AM - 12:30 PM
ORAL ABSTRACT SESSION
Breast Cancer—Local-Regional and Adjuvant Therapy
Location: N Hall B1
CME credit: 3
Track(s): Breast Cancer
Seema Ahsan Khan, MD, FACS, MPH—Co-Chair
Northwestern Memorial Hospital
Rita Nanda, MD—Co-Chair
The University of Chicago
9:30 AM ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and
bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0
breast cancer. (Abstract #CRA504)
R. Cote, A. E. Giuliano, D. Hawes, K. V. Ballman, P. W. Whitworth,
P. W. Blumencranz, D. S. Reintgen, M. Morrow, A. M. Leitch, K. Hunt
9:45 AM Primary outcome results of NSABP B-32, a randomized phase III clinical trial
to compare sentinel node resection (SNR) to conventional axillary dissection
(AD) in clinically node-negative breast cancer patients. (Abstract #LBA505)
D. N. Krag, S. J. Anderson, T. B. Julian, A. Brown, S. P. Harlow, J. P. Costantino,
T. Ashikaga, D. Weaver, E. P. Mamounas, N. Wolmark
10:00 AM ACOSOG Z0011: A randomized trial of axillary node dissection in women
with clinical T1–2 N0 M0 breast cancer who have a positive sentinel node.
(Abstract #CRA506)
A. E. Giuliano, L. M. McCall, P. D. Beitsch, P. W. Whitworth, M. Morrow,
P. W. Blumencranz, A. M. Leitch, S. Saha, K. Hunt, K. V. Ballman
10:15 AM Lumpectomy plus tamoxifen with or without irradiation in women age 70 or
older with early breast cancer. (Abstract #507)
K. S. Hughes, L. A. Schnaper, C. Cirrincione, D. A. Berry, B. McCormick,
H. B. Muss, B. Shank, C. Hudis, E. P. Winer, B. L. Smith, CALGB, ECOG, RTOG
Discussion
10:30 AM William C. Wood, MD (Abstracts #CRA504–507)
Emory University
10:45 AM Prognostic and predictive impact of biologic classification by qRT-PCR with
a 50-gene subtype predictor (PAM50) for adjuvant tamoxifen in
premenopausal breast cancer: Results from the NCIC CTG MA.12
randomized trial. (Abstract #508)
S. K. Chia, K. Ung, V. H. Bramwell, D. Tu, C. M. Perou, M. J. Ellis, P. S. Bernard,
T. Vickery, L. E. Shepherd, T. O. Nielsen
11:00 AM Recurrence risk of node-negative and ER-positive early-stage breast cancer
patients by combining recurrence score, pathologic, and clinical information:
A meta-analysis approach. (Abstract #509)
G. Tang, J. Cuzick, C. Wale, J. P. Costantino, M. Crager, S. Shak, N. Wolmark,
M. Dowsett, J. F. Forbes
11:15 AM Pharmacogenetics of tamoxifen in relation to disease-free survival in a Dutch
cohort of the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
(Abstract #510)
V. O. Dezentje, R. H. Van Schaik, J. M. Vletter - Bogaartz, J. A. Wessels,
E. T. Hille, C. Seynaeve, C. J. Van De Velde, J. W. Nortier, H. Gelderblom,
H. Guchelaar
342